Validation of a LC/MSMS method for simultaneous quantification of 9 nucleotides in biological matrices.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Feb 2019
Historique:
received: 28 05 2018
revised: 25 09 2018
accepted: 01 10 2018
entrez: 29 10 2018
pubmed: 29 10 2018
medline: 14 11 2018
Statut: ppublish

Résumé

Nucleotides play a role in inflammation processes: cAMP and cGMP in the endothelial barrier function, ADP in platelet aggregation, ATP and UTP in vasodilatation and/or vasoconstriction of blood vessels, UDP in macrophages activation. The aim of this study is to develop and validate a LC/MS-MS method able to quantify simultaneously nine nucleotides (AMP, cAMP, ADP, ATP, GMP, cGMP, UMP, UDP and UTP) in biological matrixes (cells and plasma). The method we developed, has lower LOQ's than others and has the main advantage to quantify all nucleotides within one single injection in less than 10 min. The measured nucleotides concentrations obtained with this method are similar to those obtained with assay kits commercially available. Analysis of plasma and red blood cells from healthy donors permits to estimate the physiological concentration of those nucleotides in human plasma and red blood cells, such information being poorly available in the literature. Furthermore, the protocol presented in this paper allowed us to observe that AMP, ADP, ATP concentrations are modified in human red blood cells and plasma after a venous stasis of 4 min compared to physiological blood circulation. Therefore, this specific method enables future studies on nucleotides implications in chronic inflammatory diseases but also in other pathologies where nucleotides are implicated in.

Identifiants

pubmed: 30368292
pii: S0039-9140(18)31035-X
doi: 10.1016/j.talanta.2018.10.003
pii:
doi:

Substances chimiques

Nucleotides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-214

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Melissa Cortese (M)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium; Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium. Electronic address: mecortes@ulb.ac.be.

Cédric Delporte (C)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium; Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium.

Damien Dufour (D)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium.

Caroline Noyon (C)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium.

Martin Chaumont (M)

Department of Cardiology, Erasme University Hospital, Route de Lennik 808, B-1070 Bruxelles, Belgium.

Benjamin De Becker (B)

Department of Cardiology, Erasme University Hospital, Route de Lennik 808, B-1070 Bruxelles, Belgium.

Florence Reye (F)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium.

Alexandre Rousseau (A)

Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, Route de Gozée 706, B-6110 Montigny-le-Tilleul, Belgium.

Omer Faruk Eker (OF)

Service de neuroradiologie interventionnelle, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Bron, France.

Jean Nève (J)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium.

Michael Piagnerelli (M)

Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, Route de Gozée 706, B-6110 Montigny-le-Tilleul, Belgium.

Karim Zouaoui Boudjeltia (KZ)

Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, Route de Gozée 706, B-6110 Montigny-le-Tilleul, Belgium.

Bernard Robaye (B)

Institute of Interdisciplinary Research in human and molecular Biology, Université Libre de Bruxelles, Campus de Charleroi - Gosselies (Biopark), CP300, rue des Professeurs Jeener et Brachet 12, B-6041 Charleroi, Belgium.

Pierre Van Antwerpen (P)

RD3 - Pharmacognosy, Bioanalysis and Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium; Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine CP 205/05, Boulevard du Triomphe, B-1050 Bruxelles, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH